RECALL RECORD — CLASS IIRecall closedF-0423-2023/FDA enforcement

Sheetz M.t.go!

What you need to know

Class II
  • What happened

    Product may contain undeclared sesame.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. An allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDAIN, PA, MD, OH +3 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameSheetz Distribution Services, L.l.c.
Recalling firmSheetz Distribution Services, L.l.c.Claysburg, PA, United States
UPC / barcodes
7 59465 00185 4
Lot / date codes
  • Lot Number 98447
Distribution area
INPAMDOHWVNCVA

The recalled product was distributed to retail stores in the following states: PA, MD, OH, WV, NC, VA,.

United States

Quantity affected10, 361 Individual Sandwiches
Recall initiationFDA report date: March 22, 2023
FDA recall numberF-0423-2023

Beyond the headline

The recall, in context

Sheetz Distribution Services, L.l.c. initiated this food recall on February 16, 2023. The FDA enforcement report states: Product may contain undeclared sesame. The FDA report lists distribution as: The recalled product was distributed to retail stores in the following states: PA, MD, OH, WV, NC, VA,.

The FDA enforcement report describes the reason as: Product may contain undeclared sesame.

Sheetz M.t.go! was made or distributed by Sheetz Distribution Services, L.l.c. in Claysburg, PA, United States. This page reflects FDA report F-0423-2023, dated March 22, 2023.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared sesame

Symptoms to watch for

Hives, swelling, vomiting, wheezing or anaphylaxis can occur in people with a sesame allergy.

When symptoms may appear

Reactions can begin within minutes to a few hours after eating the product.

Higher-risk groups

People with a diagnosed sesame allergy, especially children and anyone with a history of anaphylaxis.

What to do now

  1. 1Do not eat the product if you have a sesame allergy.
  2. 2Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis.
  3. 3Keep the packaging and contact the retailer or manufacturer about a refund.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Sheetz M.t.go! recall?

Sheetz Distribution Services, L.l.c. recalled Sheetz M.t.go! in an FDA Class II enforcement action reported as F-0423-2023. Product may contain undeclared sesame.

What are the symptoms of Undeclared sesame exposure?

Hives, swelling, vomiting, wheezing or anaphylaxis can occur in people with a sesame allergy.

How quickly can Undeclared sesame symptoms appear?

Reactions can begin within minutes to a few hours after eating the product.

Who is most at risk from Undeclared sesame?

People with a diagnosed sesame allergy, especially children and anyone with a history of anaphylaxis.

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat the product if you have a sesame allergy. Seek emergency care for breathing difficulty, throat swelling or other signs of anaphylaxis. Keep the packaging and contact the retailer or manufacturer about a refund.

How do I get a refund from Sheetz Distribution Services, L.l.c.?

Contact the recalling company or the retailer where you purchased the product, quote the FDA recall number and ask about a refund or replacement. Keep the packaging, lot code and proof of purchase where possible. The FDA does not issue consumer refunds. Reference FDA recall F-0423-2023 and keep the packaging, lot code and proof of purchase if you have them.

Is the Sheetz Distribution Services, L.l.c. recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0423-2023. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Sheetz Distribution Services, L.l.c.

View brand

Related alerts

Recent Undeclared allergens recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.